Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
698.00    21.00 (3.10%)
Bid:
697.00
Ask:
699.00
Spread: 2.00 (0.287%)
Market Cap: £608.13m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Annual Trading Update

8 Oct 2009 07:00

RNS Number : 4270A
Victrex PLC
08 October 2009
 



Thursday 8 October 2009

Victrex plc

Annual Trading Update

Victrex will announce its results for the year ended 30 September 2009 on Tuesday 8 December 2009. Today, the Company announces its regular annual trading update. 

Invibio

Invibio®, our biomaterials division, had an excellent year with revenue of approximately £34.1m, an increase of 37% over the previous year (£24.9m). At £16.5m, second half revenue was down 6% on the very strong first half (£17.6m) principally as a result of inventory rationalisation at certain customers.

 

Group sales volume

Encouragingly, monthly volumes have shown continued improvement throughout the second half due to increased Victrex Polymer Solutions sales. Following the low point of 88 tonnes in March, as previously announced, Group volume recovered to 110 tonnes in April, with a further increase to 142 tonnes in July. This level was sustained in August with a further increase to approximately 155 tonnes in September. Group sales volume for the year is therefore expected to be approximately 1,545 tonnes.

As a result of the sales volume achieved in the fourth quarter, whave increased polymer production levels and have recommenced monomer production.

Outlook

Overall, we expect profits for 2009 to be in line with market expectations.

Invibio continues to show strong sales performance and development potential. Accordingly, we expect further revenue growth in 2010.

While it is still too early to judge the extent to which the recovery in Victrex Polymer Solutions sales volume in the second half of 2009 is due to restocking or a higher level of sustainable demand, it represents a positive trend. However2010 sales volume will be highly dependent on the extent to which this recovery is sustained.

-Ends-

Enquiries

Victrex plc

Mike Peacock, Finance Director 01253 897700 

Hogarth Partnership Limited

Nick Denton / Barnaby Fry 0207 357 9477

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.

With over 30 years of experience, Victrex is a global manufacturer of innovative, high performance thermoplastic polymers. The Victrex Polymer Solutions Division ('VPS') is responsible for polymer business in our major industrial markets including transport, energy and electronics. The Biomaterials Solutions Division ('Invibio') provides specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTCKOKQABDDQKK
Date   Source Headline
17th May 202310:55 amRNSDirector/PDMR Shareholding
16th May 202310:03 amRNSDirector/PDMR Shareholding
12th May 202310:37 amRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
10th May 20231:34 pmRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSVictrex plc - Interim Results 2023
28th Apr 20239:33 amRNSTotal Voting Rights
18th Apr 20232:00 pmRNSHolding(s) in Company
18th Apr 202310:50 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSDirectorate Change
31st Mar 202310:52 amRNSTotal Voting Rights
20th Mar 20233:07 pmRNSHolding(s) in Company
20th Mar 202310:15 amRNSDirector/PDMR Shareholding
13th Mar 202310:14 amRNSAdditional Listing
28th Feb 20239:35 amRNSTotal Voting Rights
17th Feb 202310:06 amRNSDirector/PDMR Shareholding
14th Feb 202312:20 pmRNSDirector/PDMR Shareholding
10th Feb 20232:12 pmRNSDirector/PDMR Shareholding
10th Feb 202312:29 pmRNSResult of AGM
10th Feb 20237:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202310:43 amRNSTotal Voting Rights
17th Jan 20232:12 pmRNSDirector/PDMR Shareholding
12th Jan 20232:28 pmRNSCorrection - AGM Resolution Proposal
6th Jan 20232:58 pmRNSAnnual Report and Accounts
30th Dec 20229:00 amRNSTotal Voting Rights
22nd Dec 202211:30 amRNSDirector/PDMR Shareholding
19th Dec 202212:04 pmRNSDirector/PDMR Shareholding
19th Dec 202210:56 amRNSDirector/PDMR Shareholding
13th Dec 202211:16 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSVictrex plc – Preliminary Results 2022
1st Dec 202211:49 amRNSBlock listing Interim Review
30th Nov 20229:27 amRNSTotal Voting Rights
29th Nov 20224:05 pmRNSHolding(s) in Company
17th Nov 20222:50 pmRNSDirector/PDMR Shareholding
17th Nov 20221:35 pmRNSAdditional Listing
31st Oct 202212:55 pmRNSTotal Voting Rights
18th Oct 202212:26 pmRNSDirector/PDMR Shareholding
30th Sep 202211:03 amRNSTotal Voting Rights
28th Sep 20229:44 amRNSHolding(s) in Company
20th Sep 20224:05 pmRNSDirector/PDMR Shareholding
31st Aug 20229:00 amRNSTotal Voting Rights
17th Aug 20222:31 pmRNSDirector/PDMR Shareholding
29th Jul 202210:01 amRNSTotal Voting Rights
19th Jul 20222:41 pmRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202210:28 amRNSTotal Voting Rights
21st Jun 202212:41 pmRNSDirector/PDMR Shareholding
7th Jun 202211:45 amRNSBlock listing Interim Review
31st May 20229:59 amRNSTotal Voting Rights
27th May 20229:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.